Demographic and baseline characteristics of the study population
Characteristic . | LPA96 . | LPA99 . | P . | Total . | |||
---|---|---|---|---|---|---|---|
Median (range) . | No. (%) . | Median (range) . | No. (%) . | Median (range) . | No. (%) . | ||
Overall | — | 172 (24) | — | 560 (76) | — | — | 732 (100) |
Age, y | 39 (2-78) | — | 40 (2-83) | — | — | 40 (2-83) | — |
15 or younger | — | 11 (6) | — | 48 (9) | .83 | — | 59 (8) |
16 to 40 | — | 75 (43) | — | 240 (43) | — | — | 315 (43) |
41 to 60 | — | 57 (33) | — | 171 (30) | — | — | 228 (31) |
61 to 70 | — | 19 (11) | — | 68 (12) | — | — | 87 (12) |
71 or older | — | 10 (6) | — | 33 (6) | — | — | 43 (6) |
Sex | |||||||
Male | — | 102 (59) | — | 270 (48) | .01 | — | 372 (51) |
Female | — | 70 (41) | — | 290 (52) | — | — | 360 (49) |
ECOG score | 1 (0-3) | — | 1 (0-3) | — | — | 1 (0-3) | — |
0 to 1 | — | 130 (81) | — | 377 (73) | .07 | — | 507 (75) |
2 | — | 20 (13) | — | 102 (20) | — | — | 122 (18) |
3 | — | 10 (6) | — | 36 (7) | — | — | 46 (7) |
Fever | |||||||
No | — | 108 (63) | — | 333 (60) | .57 | — | 441 (61) |
Yes | — | 64 (37) | — | 220 (40) | — | — | 284 (39) |
WBC count, × 109/L | 2.0 (0.3-210) | — | 2.2 (0.2-460) | — | — | 2.2 (0.2-460) | — |
Less than 5 | — | 108 (62) | — | 336 (60) | .79 | — | 444 (61) |
5 to 10 | — | 21 (13) | — | 84 (15) | — | — | 105 (14) |
10 to 50 | — | 31 (18) | — | 99 (18) | — | — | 130 (18) |
50 or higher | — | 12 (7) | — | 40 (7) | — | — | 52 (7) |
PB blast count, × 109/L | 0.6 (0-210) | — | 0.7 (0-179) | 0.7 (0-210) | |||
Less than 30 | — | 151 (93) | — | 459 (90) | .35 | — | 610 (91) |
30 or higher | — | 12 (7) | — | 50 (10) | — | — | 62 (9) |
Platelet count, × 109/L | 20 (1-161) | — | 22 (1-207) | — | — | 22 (1-207) | — |
Less than 40 | — | 132 (77) | — | 431 (77) | .37 | — | 563 (77) |
40 or higher | — | 40 (23) | — | 128 (23) | — | — | 168 (23) |
Hemoglobin level, g/dL | 9.4 (4.3-15.2) | — | 9.2 (3-16.9) | — | — | 9.3 (3-16.9) | — |
Less than 10 | — | 104 (60) | — | 361 (65) | .26 | — | 465 (64) |
10 or higher | — | 68 (40) | — | 198 (35) | — | — | 266 (36) |
Creatinine level, mg/dL | 0.9 (0.2-1.7) | — | 0.9 (0.2-2.4) | — | — | 0.9 (0.2-2.4) | — |
Less than 1.4 | — | 171 (99) | — | 525 (98) | .22 | — | 696 (98) |
1.4 or higher | — | 1 (1) | — | 13 (2) | — | — | 14 (2) |
Coagulopathy | |||||||
No | — | 51 (30) | — | 141 (28) | .61 | — | 192 (28) |
Yes | — | 121 (70) | — | 369 (72) | — | — | 490 (72) |
Uric acid level, mg/dL | 3.8 (1-9.6) | — | 3.9 (0.29-12.7) | — | — | 3.8 (0.29-12.7) | — |
Less than 7 | — | 152 (95) | — | 442 (94) | .65 | — | 594 (94) |
7 or higher | — | 8 (5) | — | 28 (6) | — | — | 36 (6) |
Fibrinogen level, mg/dL | 160 (0-784) | — | 158 (0-862) | — | — | 158 (0-862) | — |
Less than 170 | — | 91 (30) | — | 285 (28) | .89 | — | 376 (28) |
170 or higher | — | 76 (70) | — | 232 (72) | — | — | 308 (72) |
Albumin level, g/dL | 4.1 (2.2-6.2) | — | 4 (1.7-6.7) | — | — | 4 (1.7-6.7) | — |
Less than 3.5 | — | 22 (14) | — | 107 (24) | .01 | — | 129 (22) |
3.5 or higher | — | 129 (86) | — | 333 (76) | — | — | 462 (78) |
Morphologic subtype | |||||||
Hypergranular | — | 143 (83) | — | 450 (82) | .7 | — | 593 (82) |
Microgranular | — | 29 (17) | — | 100 (18) | — | — | 129 (18) |
PML/RARα isoform | |||||||
BCR1/BCR2 | — | 91 (56) | — | 286 (59) | .42 | — | 377 (58) |
BCR3 | — | 73 (44) | — | 198 (41) | — | — | 271 (42) |
Characteristic . | LPA96 . | LPA99 . | P . | Total . | |||
---|---|---|---|---|---|---|---|
Median (range) . | No. (%) . | Median (range) . | No. (%) . | Median (range) . | No. (%) . | ||
Overall | — | 172 (24) | — | 560 (76) | — | — | 732 (100) |
Age, y | 39 (2-78) | — | 40 (2-83) | — | — | 40 (2-83) | — |
15 or younger | — | 11 (6) | — | 48 (9) | .83 | — | 59 (8) |
16 to 40 | — | 75 (43) | — | 240 (43) | — | — | 315 (43) |
41 to 60 | — | 57 (33) | — | 171 (30) | — | — | 228 (31) |
61 to 70 | — | 19 (11) | — | 68 (12) | — | — | 87 (12) |
71 or older | — | 10 (6) | — | 33 (6) | — | — | 43 (6) |
Sex | |||||||
Male | — | 102 (59) | — | 270 (48) | .01 | — | 372 (51) |
Female | — | 70 (41) | — | 290 (52) | — | — | 360 (49) |
ECOG score | 1 (0-3) | — | 1 (0-3) | — | — | 1 (0-3) | — |
0 to 1 | — | 130 (81) | — | 377 (73) | .07 | — | 507 (75) |
2 | — | 20 (13) | — | 102 (20) | — | — | 122 (18) |
3 | — | 10 (6) | — | 36 (7) | — | — | 46 (7) |
Fever | |||||||
No | — | 108 (63) | — | 333 (60) | .57 | — | 441 (61) |
Yes | — | 64 (37) | — | 220 (40) | — | — | 284 (39) |
WBC count, × 109/L | 2.0 (0.3-210) | — | 2.2 (0.2-460) | — | — | 2.2 (0.2-460) | — |
Less than 5 | — | 108 (62) | — | 336 (60) | .79 | — | 444 (61) |
5 to 10 | — | 21 (13) | — | 84 (15) | — | — | 105 (14) |
10 to 50 | — | 31 (18) | — | 99 (18) | — | — | 130 (18) |
50 or higher | — | 12 (7) | — | 40 (7) | — | — | 52 (7) |
PB blast count, × 109/L | 0.6 (0-210) | — | 0.7 (0-179) | 0.7 (0-210) | |||
Less than 30 | — | 151 (93) | — | 459 (90) | .35 | — | 610 (91) |
30 or higher | — | 12 (7) | — | 50 (10) | — | — | 62 (9) |
Platelet count, × 109/L | 20 (1-161) | — | 22 (1-207) | — | — | 22 (1-207) | — |
Less than 40 | — | 132 (77) | — | 431 (77) | .37 | — | 563 (77) |
40 or higher | — | 40 (23) | — | 128 (23) | — | — | 168 (23) |
Hemoglobin level, g/dL | 9.4 (4.3-15.2) | — | 9.2 (3-16.9) | — | — | 9.3 (3-16.9) | — |
Less than 10 | — | 104 (60) | — | 361 (65) | .26 | — | 465 (64) |
10 or higher | — | 68 (40) | — | 198 (35) | — | — | 266 (36) |
Creatinine level, mg/dL | 0.9 (0.2-1.7) | — | 0.9 (0.2-2.4) | — | — | 0.9 (0.2-2.4) | — |
Less than 1.4 | — | 171 (99) | — | 525 (98) | .22 | — | 696 (98) |
1.4 or higher | — | 1 (1) | — | 13 (2) | — | — | 14 (2) |
Coagulopathy | |||||||
No | — | 51 (30) | — | 141 (28) | .61 | — | 192 (28) |
Yes | — | 121 (70) | — | 369 (72) | — | — | 490 (72) |
Uric acid level, mg/dL | 3.8 (1-9.6) | — | 3.9 (0.29-12.7) | — | — | 3.8 (0.29-12.7) | — |
Less than 7 | — | 152 (95) | — | 442 (94) | .65 | — | 594 (94) |
7 or higher | — | 8 (5) | — | 28 (6) | — | — | 36 (6) |
Fibrinogen level, mg/dL | 160 (0-784) | — | 158 (0-862) | — | — | 158 (0-862) | — |
Less than 170 | — | 91 (30) | — | 285 (28) | .89 | — | 376 (28) |
170 or higher | — | 76 (70) | — | 232 (72) | — | — | 308 (72) |
Albumin level, g/dL | 4.1 (2.2-6.2) | — | 4 (1.7-6.7) | — | — | 4 (1.7-6.7) | — |
Less than 3.5 | — | 22 (14) | — | 107 (24) | .01 | — | 129 (22) |
3.5 or higher | — | 129 (86) | — | 333 (76) | — | — | 462 (78) |
Morphologic subtype | |||||||
Hypergranular | — | 143 (83) | — | 450 (82) | .7 | — | 593 (82) |
Microgranular | — | 29 (17) | — | 100 (18) | — | — | 129 (18) |
PML/RARα isoform | |||||||
BCR1/BCR2 | — | 91 (56) | — | 286 (59) | .42 | — | 377 (58) |
BCR3 | — | 73 (44) | — | 198 (41) | — | — | 271 (42) |
ECOG indicates Eastern Cooperative Oncology Group; WBC, white blood count; PB, peripheral blood; and —, not applicable.